A new review in Frontiers in Dementia examines the growing body of research connecting hearing loss with cognitive decline and dementia risk—while underscoring that key questions about how, why, and when these conditions are linked remain unresolved. The paper also argues that, beyond risk reduction, hearing loss frequently co-occurs with dementia in real-world practice, strengthening the case for more integrated approaches to hearing and cognitive care.
Across audiology, otology, geriatrics, and primary care, the link between hearing loss and dementia has become a frequent topic—especially after dementia prevention frameworks brought hearing health into sharper focus.
Still, the authors emphasize that the field is moving from association to understanding, and that translation into targeted interventions is not straightforward.
Risk: Why Hearing Loss Remains a Major Focus in Dementia Prevention
The review summarizes evidence that hearing loss—particularly from midlife onward—has been repeatedly associated with increased dementia risk in longitudinal studies. Because hearing loss is so common, even modest increases in individual-level risk can have important population-level implications.
The authors note that the prominence of hearing loss in major dementia prevention discussions has played a significant role in raising awareness and stimulating research in the past decade.
At the same time, the researchers caution that public-facing interpretations can easily become overconfident. They write, “Hearing loss in midlife is an important and potentially modifiable risk factor for the development of dementia.” However, they also stress that “evidence for the mechanisms linking the two conditions is inconclusive,” which continues to limit the development of targeted interventions.
For clinicians, that distinction matters. A “modifiable risk factor” does not mean that treating hearing loss will reliably prevent dementia for any given patient. It does mean that hearing health is a meaningful and actionable part of healthy aging—and one that intersects with other factors known to influence cognition and function, including social engagement, mental health, and cardiovascular risk.
Mechanisms: Several Plausible Pathways, Likely Working Together
A major focus of the review is the current state of mechanistic evidence. Rather than pointing to a single explanation, the authors describe multiple plausible pathways that could link hearing loss and dementia, potentially acting together and varying across individuals and across the life course.
In the discussion, the investigators describe the state of evidence this way: “Evidence shows that the association between dementia and hearing loss is biologically plausible; supported by multiple hypothesized mechanisms. However these may not operate in isolation.” They go on to note that the likely mechanisms include sensory deprivation, increased cognitive load (listening effort), vascular and neurodegenerative processes, and shared genetic/biological risk factors.
From a practical standpoint, this framing helps explain why the evidence can look “mixed” depending on the population studied and how hearing is measured. The review suggests that midlife hearing loss may align more consistently with long-term causal pathways. In later life, however, associations may increasingly reflect shared aging-related pathology or early (prodromal) neurodegenerative change—meaning hearing difficulty could sometimes be a consequence or early sign of brain disease rather than a primary cause.
The authors highlight emerging conceptual models intended to integrate these pathways, including frameworks that view hearing loss as a cause, catalyst, or consequence depending on timing and context. For clinicians counseling patients, the takeaway is to avoid a one-size-fits-all narrative. The “why” behind a patient’s hearing difficulty—and what that means for cognitive risk—may differ substantially across age, medical history, and functional presentation.
Do Hearing Interventions Change Cognitive Outcomes?
The review also addresses a central clinical question: if hearing loss is linked with dementia risk, does treating hearing loss change cognitive trajectories or disease progression?
The investigators note that, despite extensive associative evidence, stronger experimental evidence remains limited. As they write, “Despite a wealth of associative evidence, we lack substantive experimental evidence for hearing interventions to prevent or meaningfully slow cognitive decline in the general population.” The authors point to ongoing work aimed at better targeting—identifying which groups may benefit most, and at what point across the life course intervention is most likely to matter.
This is where the evidence base can be challenging for both clinicians and patients. Observational studies may show better outcomes among hearing aid users, but those studies can be influenced by differences between users and non-users (such as health behaviors, access to care, education, and baseline cognition). Randomized trials can address some of these concerns, but are difficult to run over long time horizons, and often vary in outcomes measured and follow-up duration.
Importantly, the authors emphasize that the value of hearing interventions does not hinge on proving dementia prevention. Hearing aids, cochlear implants, and rehabilitative support can meaningfully improve access to communication, listening confidence, and social participation—outcomes that matter for all patients and can be especially relevant for those already experiencing cognitive change.
Clinical Implications: Hearing Care as Part of Holistic Dementia Care
Beyond the prevention debate, the review highlights a real-world reality: hearing loss and dementia frequently co-occur. That comorbidity can compound functional challenges, increase caregiver burden, and make clinical encounters more difficult.
When hearing loss is missed or unmanaged, patients may appear less engaged, struggle with instructions, or withdraw from conversations—factors that can be misattributed to cognition alone.
The authors also note that many dementia-related supports and non-pharmacological interventions depend on communication and engagement. In that context, optimizing hearing can be an enabling step—supporting participation in therapies and improving day-to-day interactions with family, caregivers, and clinical teams.
The review highlights a practical reality for clinicians: hearing loss and dementia frequently co-occur, and when unmanaged, hearing difficulty can compound functional challenges, increase caregiver burden, and interfere with effective communication in clinical and everyday settings. Optimizing hearing can support patient engagement, improve participation in care, and reduce avoidable communication-related barriers.
Looking ahead, the authors call for continued research to better understand mechanisms, refine intervention strategies, and clarify which patients are most likely to benefit from hearing care in the context of cognitive health.
While important questions remain, the current evidence supports a balanced conclusion—hearing loss is a meaningful, potentially modifiable risk factor for dementia, and addressing hearing health remains an important component of patient-centered care across the lifespan.
Citation:
Broome EE, Calvert S, Heffernan E, Henshaw H, Khan A, Pelekanos V, Sollini J, Stancel-Lewis J and Dening T (2026) Dementia and hearing loss: from risk to mechanisms and management. Front. Dement. 5:1736003. doi: 10.3389/frdem.2026.1736003
